.png)
All Vaccine Market By Type (Conjugate, Inactivated, Live Attenuated, Toxoid and Other Vaccine Types), Valance (Multivalent and Monovalent), Route of Administration (Injectable (Subcutaneous & Intramuscular), Oral and Other Route of Administrations), Indication (Human Papilloma Virus, Influenza, Meningococcal Disease, MMR, Hepatitis, Polio, DTP, Rotavirus, Pneumococcal Disease and Other Indications) and Distribution Channel (Retail Pharmacies, Institutional Sales and Hospital Pharmacies) - Global Industry Analysis And Forecast To 2027
Published On : September 2018 Pages : 180 Category: Pharma & Healthcare Report Code : HC091275
SEGMENTS & REGIONS:
- By Type: Conjugate, Inactivated, Live Attenuated, Toxoid and Other Vaccine Types
- Valance: Multivalent and Monovalent
- Route of Administration: Injectable (Subcutaneous & Intramuscular
- Indication: Human Papilloma Virus, Influenza, Meningococcal Disease, MMR, Hepatitis, Polio, DTP, Rotavirus, Pneumococcal Disease and Other Indications
- and Distribution Channel: Retail Pharmacies, Institutional Sales and Hospital Pharmacies
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Industry Outlook
Vaccine is a medication that is administered to avert diseases. Vaccine is related to disease causing microorganisms and prepared by agents like killed or weakened microbes, toxins or some of its surface proteins. Vaccine provides active immunity against some harmful agents by activating the immune system. Vaccines are administered into the body by oral route or injections. Use of Vaccines in growing due to; increasing number of cases various infectious diseases like malaria, measles, dengue, HIV, hepatitis and others, governments initiatives like vaccination programs, rising awareness amongst the population, rise in the R&D in medicine sector, etc. Therefore, the All Vaccine Market is anticipated to expand and has tremendous scope during the forecast period. The global All Vaccine Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
The global All Vaccine Market is based on segment, by Type the market is segmented into Conjugate, Inactivated, Live Attenuated, Toxoid and Other Vaccine Types, by Valance the market is segmented into Multivalent and Monovalent, by Route of Administration the market is segmented into Injectable (Subcutaneous & Intramuscular), Oral and Other Route of Administrations, by Indication the market is segmented into Human Papilloma Virus, Influenza, Meningococcal Disease, MMR, Hepatitis, Polio, DTP, Rotavirus, Pneumococcal Disease and Other Indications, and by Distribution Channel the market is segmented into Retail Pharmacies, Institutional Sales and Hospital Pharmacies.
- All Vaccine Market, By Type
- Conjugate
- Inactivated
- Live Attenuated
- Toxoid
- Other Vaccine Types
- All Vaccine Market, By Valance
- Multivalent
- Monovalent
- All Vaccine Market, By Route of Administration
- Injectable
- Subcutaneous
- Intramuscular
- Oral
- Other Route of Administrations
- All Vaccine Market, By Indication
- Human Papilloma Virus
- Influenza
- Meningococcal Disease
- MMR
- Hepatitis
- Polio
- DTP
- Rotavirus
- Pneumococcal Disease
- Other Indications
- All Vaccine Market, By Distribution Channel
- Retail Pharmacies
- Institutional Sales
- Hospital Pharmacies
Regional Insights
On a global front, the All Vaccine Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the All Vaccine Market owing to constant R&D in the pharmaceutical sector & also launch of number of new vaccines.
All Vaccine Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The leading players in the market are Pfizer Inc., Mitsubishi Tanabe Pharma Corporation, CSL Ltd., Emergent BioSolutions Inc., GlaxoSmithKline plc., Sanofi Pasteur SA, Novavax AB, Janssen Pharmaceutical Company, Merck & Co. Inc. and Serum Institute of India Ltd.. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Pfizer Inc.
- Mitsubishi Tanabe Pharma Corporation
- CSL Ltd.
- Emergent BioSolutions Inc.
- GlaxoSmithKline plc.
- Sanofi Pasteur SA
- Novavax AB
- Janssen Pharmaceutical Company
- Merck & Co. Inc.
- Serum Institute of India Ltd.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o All Vaccine Market, By Vaccine Type, Estimates and Forecast, 2017-2027 ($Million)
o Conjugate
o Inactivated
o Live Attenuated
o Toxoid
o Other Vaccine Types
o All Vaccine Market, By Valance, Estimates and Forecast, 2017-2027 ($Million)
o Multivalent
o Monovalent
o All Vaccine Market, By Route of Administration, Estimates and Forecast, 2017-2027 ($Million)
o Injectable
§ Subcutaneous
§ Intramuscular
o Oral
o Other Route of Administrations
o All Vaccine Market, By Indication, Estimates and Forecast, 2017-2027 ($Million)
o Human Papilloma Virus
o Influenza
o Meningococcal Disease
o MMR
o Hepatitis
o Polio
o DTP
o Rotavirus
o Pneumococcal Disease
o Other Indications
o All Vaccine Market, By Distribution Channel, Estimates and Forecast, 2017-2027 ($Million)
o Retail Pharmacies
o Institutional Sales
o Hospital Pharmacies
All Vaccine Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America All Vaccine Market, By Country
o U.S. All Vaccine Market
o Canada All Vaccine Market
o Mexico All Vaccine Market
o Europe
§ Europe All Vaccine Market, By Country
o Germany All Vaccine Market
o UK All Vaccine Market
o France All Vaccine Market
o Russia All Vaccine Market
o Italy All Vaccine Market
o Rest of Europe All Vaccine Market
o Asia-Pacific
§ Asia-Pacific All Vaccine Market, By Country
o China All Vaccine Market
o Japan All Vaccine Market
o South Korea All Vaccine Market
o India All Vaccine Market
o Southeast Asia All Vaccine Market
o Rest of Asia-Pacific All Vaccine Market
o South America
§ South America All Vaccine Market, By Country
o Brazil All Vaccine Market
o Argentina All Vaccine Market
o Columbia All Vaccine Market
o Rest of South America All Vaccine Market
o Middle East and Africa
§ Middle East and Africa All Vaccine Market, By Country
o Saudi Arabia All Vaccine Market
o UAE All Vaccine Market
o Egypt All Vaccine Market
o Nigeria All Vaccine Market
o South Africa All Vaccine Market
o Rest of MEA All Vaccine Market
Table of Contents
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. All Vaccine Market, By Type
5.1. Introduction
5.2. Global All Vaccine Revenue and Market Share by Type (2017-2027)
5.2.1. Global All Vaccine Revenue and Revenue Share by Type (2017-2027)
5.3. Conjugate
5.3.1. Global Conjugate Revenue and Growth Rate (2017-2027)
5.4. Inactivated
5.4.1. Global Inactivated Revenue and Growth Rate (2017-2027)
5.5. Live Attenuated
5.5.1. Global Live Attenuated Revenue and Growth Rate (2017-2027)
5.6. Toxoid
5.6.1. Global Toxoid Revenue and Growth Rate (2017-2027)
5.7. Other Vaccine Types
5.7.1. Global Other Vaccine Types Revenue and Growth Rate (2017-2027)
6. All Vaccine Market, By Valance
6.1. Introduction
6.2. Global All Vaccine Revenue and Market Share by Valance (2017-2027)
6.2.1. Global All Vaccine Revenue and Revenue Share by Valance (2017-2027)
6.3. Multivalent
6.3.1. Global Multivalent Revenue and Growth Rate (2017-2027)
6.4. Monovalent
6.4.1. Global Monovalent Revenue and Growth Rate (2017-2027)
7. All Vaccine Market, By Route Of Administration
7.1. Introduction
7.2. Global All Vaccine Revenue and Market Share by Route Of Administration (2017-2027)
7.2.1. Global All Vaccine Revenue and Revenue Share by Route Of Administration (2017-2027)
7.3. Injectable
7.3.1. Global Injectable Revenue and Growth Rate (2017-2027)
7.3.2. Global Injectable By Type (2017-2027)
7.3.3. Subcutaneous
7.3.3.1. Global Subcutaneous Revenue and Growth Rate (2017-2027)
7.3.4. Intramuscular
7.3.4.1. Global Intramuscular Revenue and Growth Rate (2017-2027)
7.4. Oral
7.4.1. Global Oral Revenue and Growth Rate (2017-2027)
7.5. Other Route of Administrations
7.5.1. Global Other Route of Administrations Revenue and Growth Rate (2017-2027)
8. All Vaccine Market, By Indication
8.1. Introduction
8.2. Global All Vaccine Revenue and Market Share by Indication (2017-2027)
8.2.1. Global All Vaccine Revenue and Revenue Share by Indication (2017-2027)
8.3. Human Papilloma Virus
8.3.1. Global Human Papilloma Virus Revenue and Growth Rate (2017-2027)
8.4. Influenza
8.4.1. Global Influenza Revenue and Growth Rate (2017-2027)
8.5. Meningococcal Disease
8.5.1. Global Meningococcal Disease Revenue and Growth Rate (2017-2027)
8.6. MMR
8.6.1. Global MMR Revenue and Growth Rate (2017-2027)
8.7. Hepatitis
8.7.1. Global Hepatitis Revenue and Growth Rate (2017-2027)
8.8. Polio
8.8.1. Global Polio Revenue and Growth Rate (2017-2027)
8.9. DTP
8.9.1. Global DTP Revenue and Growth Rate (2017-2027)
8.10. Rotavirus
8.10.1. Global Rotavirus Revenue and Growth Rate (2017-2027)
8.11. Pneumococcal Disease
8.11.1. Global Pneumococcal Disease Revenue and Growth Rate (2017-2027)
8.12. Other Indications
8.12.1. Global Other Indications Revenue and Growth Rate (2017-2027)
9. All Vaccine Market, By Distribution Channel
9.1. Introduction
9.2. Global All Vaccine Revenue and Market Share by Distribution Channel (2017-2027)
9.2.1. Global All Vaccine Revenue and Revenue Share by Distribution Channel (2017-2027)
9.3. Retail Pharmacies
9.3.1. Global Retail Pharmacies Revenue and Growth Rate (2017-2027)
9.4. Institutional Sales
9.4.1. Global Institutional Sales Revenue and Growth Rate (2017-2027)
9.5. Hospital Pharmacies
9.5.1. Global Hospital Pharmacies Revenue and Growth Rate (2017-2027)
10. All Vaccine Market, By Region
10.1. Introduction
10.2. Global All Vaccine Revenue and Market Share by Regions
10.2.1. Global All Vaccine Revenue by Regions (2017-2027)
10.3. North America All Vaccine by Countries
10.3.1. North America All Vaccine Revenue and Growth Rate (2017-2027)
10.3.2. North America All Vaccine Revenue (Million USD) by Countries (2017-2027)
10.3.3. United States
10.3.3.1. United States All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.3.4. Canada
10.3.4.1. Canada All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.3.5. Mexico
10.3.5.1. Mexico All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.4. Europe All Vaccine by Countries
10.4.1. Europe All Vaccine Revenue and Growth Rate (2017-2027)
10.4.2. Europe All Vaccine Revenue (Million USD) by Countries (2017-2027)
10.4.3. Germany
10.4.3.1. Germany All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.4.4. France
10.4.4.1. France All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.4.5. UK
10.4.5.1. UK All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.4.6. Russia
10.4.6.1. Russia All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.4.7. Italy
10.4.7.1. Italy All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.4.8. Rest of Europe
10.4.8.1. Rest of Europe All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.5. Asia-Pacific All Vaccine by Countries
10.5.1. Asia-Pacific All Vaccine Revenue and Growth Rate (2017-2027)
10.5.2. Asia-Pacific All Vaccine Revenue (Million USD) by Countries (2017-2027)
10.5.3. China
10.5.3.1. China All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.5.4. Japan
10.5.4.1. Japan All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.5.5. Korea
10.5.5.1. Korea All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.5.6. India
10.5.6.1. India All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.5.7. Southeast Asia
10.5.7.1. Southeast Asia All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.5.8. Rest of Asia-Pacific
10.5.8.1. Rest of Asia-Pacific All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.6. South America All Vaccine by Countries
10.6.1. South America All Vaccine Revenue and Growth Rate (2017-2027)
10.6.2. South America All Vaccine Revenue (Million USD) by Countries (2017-2027)
10.6.3. Brazil
10.6.3.1. Brazil All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.6.4. Argentina
10.6.4.1. Argentina All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.6.5. Columbia
10.6.5.1. Columbia All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.6.6. Rest of South America
10.6.6.1. Rest of South America All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.7. Middle East and Africa All Vaccine by Countries
10.7.1. Middle East and Africa All Vaccine Revenue and Growth Rate (2017-2027)
10.7.2. Middle East and Africa All Vaccine Revenue (Million USD) by Countries (2017-2027)
10.7.3. Saudi Arabia
10.7.3.1. Saudi Arabia All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.4. United Arab Emirates
10.7.4.1. United Arab Emirates All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.5. Egypt
10.7.5.1. Egypt All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.6. Nigeria
10.7.6.1. Nigeria All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.7. South Africa
10.7.7.1. South Africa All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.8. Turkey
10.7.8.1. Turkey All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.9. Rest of Middle East and Africa
10.7.9.1. Rest of Middle East and Africa All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
11. Company Profiles
11.1. Pfizer Inc.
11.1.1. Business Overview
11.1.2. Service Portfolio
11.1.3. Strategic Developments
11.1.4. Revenue and Market Share
11.2. Mitsubishi Tanabe Pharma Corporation
11.2.1. Business Overview
11.2.2. Service Portfolio
11.2.3. Strategic Developments
11.2.4. Revenue and Market Share
11.3. CSL Ltd.
11.3.1. Business Overview
11.3.2. Service Portfolio
11.3.3. Strategic Developments
11.3.4. Revenue and Market Share
11.4. Emergent BioSolutions Inc.
11.4.1. Business Overview
11.4.2. Service Portfolio
11.4.3. Strategic Developments
11.4.4. Revenue and Market Share
11.5. GlaxoSmithKline plc.
11.5.1. Business Overview
11.5.2. Service Portfolio
11.5.3. Strategic Developments
11.5.4. Revenue and Market Share
11.6. Sanofi Pasteur SA
11.6.1. Business Overview
11.6.2. Service Portfolio
11.6.3. Strategic Developments
11.6.4. Revenue and Market Share
11.7. Novavax AB
11.7.1. Business Overview
11.7.2. Service Portfolio
11.7.3. Strategic Developments
11.7.4. Revenue and Market Share
11.8. Janssen Pharmaceutical Company
11.8.1. Business Overview
11.8.2. Service Portfolio
11.8.3. Strategic Developments
11.8.4. Revenue and Market Share
11.9. Merck & Co. Inc.
11.9.1. Business Overview
11.9.2. Service Portfolio
11.9.3. Strategic Developments
11.9.4. Revenue and Market Share
11.10. Serum Institute of India Ltd.
11.10.1. Business Overview
11.10.2. Service Portfolio
11.10.3. Strategic Developments
11.10.4. Revenue and Market Share
12. Global All Vaccine Market Competition, by Manufacturer
12.1. Global All Vaccine Revenue and Market Share by Manufacturer (2017-2017)
12.2. Global All Vaccine Price By Region (2017-2017)
12.3. Top 5 All Vaccine Manufacturer Market Share
12.4. Market Competition Trend
13. All Vaccine Market Forecast (2017-2027)
13.1. Global All Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
13.2. All Vaccine Market Forecast by Regions (2017-2027)
13.2.1. North America All Vaccine Market Forecast (2017-2027)
13.2.1.1. United States All Vaccine Market Forecast (2017-2027)
13.2.1.2. Canada All Vaccine Market Forecast (2017-2027)
13.2.1.3. Mexico All Vaccine Market Forecast (2017-2027)
13.2.2. Europe All Vaccine Market Forecast (2017-2027)
13.2.2.1. Germany All Vaccine Market Forecast (2017-2027)
13.2.2.2. France All Vaccine Market Forecast (2017-2027)
13.2.2.3. UK All Vaccine Market Forecast (2017-2027)
13.2.2.4. Russia All Vaccine Market Forecast (2017-2027)
13.2.2.5. Italy All Vaccine Market Forecast (2017-2027)
13.2.2.6. Rest of Europe All Vaccine Market Forecast (2017-2027)
13.2.3. Asia-Pacific All Vaccine Market Forecast (2017-2027)
13.2.3.1. China All Vaccine Market Forecast (2017-2027)
13.2.3.2. Japan All Vaccine Market Forecast (2017-2027)
13.2.3.3. Korea All Vaccine Market Forecast (2017-2027)
13.2.3.4. India All Vaccine Market Forecast (2017-2027)
13.2.3.5. Southeast Asia All Vaccine Market Forecast (2017-2027)
13.2.3.6. Rest of Asia-Pacific All Vaccine Market Forecast (2017-2027)
13.2.4. South America All Vaccine Market Forecast (2017-2027)
13.2.4.1. Brazil All Vaccine Market Forecast (2017-2027)
13.2.4.2. Argentina All Vaccine Market Forecast (2017-2027)
13.2.4.3. Columbia All Vaccine Market Forecast (2017-2027)
13.2.4.4. Rest of South America All Vaccine Market Forecast (2017-2027)
13.2.5. Middle East and Africa All Vaccine Market Forecast (2017-2027)
13.2.5.1. Saudi Arabia All Vaccine Market Forecast (2017-2027)
13.2.5.2. United Arab Emirates All Vaccine Market Forecast (2017-2027)
13.2.5.3. Egypt All Vaccine Market Forecast (2017-2027)
13.2.5.4. Nigeria All Vaccine Market Forecast (2017-2027)
13.2.5.5. South Africa All Vaccine Market Forecast (2017-2027)
13.2.5.6. Turkey All Vaccine Market Forecast (2017-2027)
13.2.5.7. Rest of Middle East and Africa All Vaccine Market Forecast (2017-2027)
13.3. All Vaccine Market Forecast by Type (2017-2027)
13.3.1. All Vaccine Forecast by Type (2017-2027)
13.3.2. All Vaccine Market Share Forecast by Type (2017-2027)
13.4. All Vaccine Market Forecast by Valance (2017-2027)
13.4.1. All Vaccine Forecast by Valance (2017-2027)
13.4.2. All Vaccine Market Share Forecast by Valance (2017-2027)
13.5. All Vaccine Market Forecast by Route Of Administration (2017-2027)
13.5.1. All Vaccine Forecast by Route Of Administration (2017-2027)
13.5.2. All Vaccine Market Share Forecast by Route Of Administration (2017-2027)
13.6. All Vaccine Market Forecast by Indication (2017-2027)
13.6.1. All Vaccine Forecast by Indication (2017-2027)
13.6.2. All Vaccine Market Share Forecast by Indication (2017-2027)
13.7. All Vaccine Market Forecast by Distribution Channel (2017-2027)
13.7.1. All Vaccine Forecast by Distribution Channel (2017-2027)
All Vaccine Market Share Forecast by Distribution Channel (2017-2027)
List of Tables
14. List of Tables and Figures
Figure United States All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure France All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure China All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure India All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa All Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Table Global All Vaccine Revenue and Revenue Share by Type (2017-2018)
Figure Global Conjugate Revenue and Growth Rate (2017-2018)
Figure Global Inactivated Revenue and Growth Rate (2017-2018)
Figure Global Live Attenuated Revenue and Growth Rate (2017-2018)
Figure Global Toxoid Revenue and Growth Rate (2017-2018)
Figure Global Other Vaccine Types Revenue and Growth Rate (2017-2018)
Table Global All Vaccine Revenue and Revenue Share by Valance (2017-2018)
Figure Global Multivalent Revenue and Growth Rate (2017-2018)
Figure Global Monovalent Revenue and Growth Rate (2017-2018)
Table Global All Vaccine Revenue and Revenue Share by Route Of Administration (2017-2018)
Figure Global Injectable Revenue and Growth Rate (2017-2018)
Figure Global Subcutaneous Revenue and Growth Rate (2017-2018)
Figure Global Intramuscular Revenue and Growth Rate (2017-2018)
Figure Global Oral Revenue and Growth Rate (2017-2018)
Figure Global Other Route of Administrations Revenue and Growth Rate (2017-2018)
Table Global All Vaccine Revenue and Revenue Share by Indication (2017-2018)
Figure Global Human Papilloma Virus Revenue and Growth Rate (2017-2018)
Figure Global Influenza Revenue and Growth Rate (2017-2018)
Figure Global Meningococcal Disease Revenue and Growth Rate (2017-2018)
Figure Global MMR Revenue and Growth Rate (2017-2018)
Figure Global Hepatitis Revenue and Growth Rate (2017-2018)
Figure Global Polio Revenue and Growth Rate (2017-2018)
Figure Global DTP Revenue and Growth Rate (2017-2018)
Figure Global Rotavirus Revenue and Growth Rate (2017-2018)
Figure Global Pneumococcal Disease Revenue and Growth Rate (2017-2018)
Figure Global Other Indications Revenue and Growth Rate (2017-2018)
Table Global All Vaccine Revenue and Revenue Share by Distribution Channel (2017-2018)
Figure Global Retail Pharmacies Revenue and Growth Rate (2017-2018)
Figure Global Institutional Sales Revenue and Growth Rate (2017-2018)
Figure Global Hospital Pharmacies Revenue and Growth Rate (2017-2018)
Table Global All Vaccine Revenue by Regions (2017-2018)
Figure North America All Vaccine Growth Rate (2017-2018)
Figure North America All Vaccine Revenue and Growth Rate (2017-2018)
Figure North America All Vaccine by Countries (2017-2018)
Figure North America All Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure United States All Vaccine Growth Rate (2017-2018)
Figure United States All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada All Vaccine Growth Rate (2017-2018)
Figure Canada All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico All Vaccine Growth Rate (2017-2018)
Figure Mexico All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe All Vaccine Growth Rate (2017-2018)
Figure Europe All Vaccine Revenue and Growth Rate (2017-2018)
Figure Europe All Vaccine by Countries (2017-2018)
Figure Europe All Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure Germany All Vaccine Growth Rate (2017-2018)
Figure Germany All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France All Vaccine Growth Rate (2017-2018)
Figure France All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK All Vaccine Growth Rate (2017-2018)
Figure UK All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia All Vaccine Growth Rate (2017-2018)
Figure Russia All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy All Vaccine Growth Rate (2017-2018)
Figure Italy All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe All Vaccine Growth Rate (2017-2018)
Figure Rest of Europe All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific All Vaccine Growth Rate (2017-2018)
Figure Asia-Pacific All Vaccine Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific All Vaccine by Countries (2017-2018)
Figure Asia-Pacific All Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure China All Vaccine Growth Rate (2017-2018)
Figure China All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan All Vaccine Growth Rate (2017-2018)
Figure Japan All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea All Vaccine Growth Rate (2017-2018)
Figure Korea All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India All Vaccine Growth Rate (2017-2018)
Figure India All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia All Vaccine Growth Rate (2017-2018)
Figure Southeast Asia All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific All Vaccine Growth Rate (2017-2018)
Figure Rest of Asia-Pacific All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America All Vaccine Growth Rate (2017-2018)
Figure South America All Vaccine Revenue and Growth Rate (2017-2018)
Figure South America All Vaccine by Countries (2017-2018)
Figure South America All Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure Brazil All Vaccine Growth Rate (2017-2018)
Figure Brazil All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina All Vaccine Growth Rate (2017-2018)
Figure Argentina All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia All Vaccine Growth Rate (2017-2018)
Figure Columbia All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America All Vaccine Growth Rate (2017-2018)
Figure Rest of South America All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa All Vaccine Growth Rate (2017-2018)
Figure Middle East and Africa All Vaccine Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa All Vaccine by Countries (2017-2018)
Figure Middle East and Africa All Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia All Vaccine Growth Rate (2017-2018)
Figure Saudi Arabia All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates All Vaccine Growth Rate (2017-2018)
Figure United Arab Emirates All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt All Vaccine Growth Rate (2017-2018)
Figure Egypt All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria All Vaccine Growth Rate (2017-2018)
Figure Nigeria All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa All Vaccine Growth Rate (2017-2018)
Figure South Africa All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey All Vaccine Growth Rate (2017-2018)
Figure Turkey All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa All Vaccine Growth Rate (2017-2018)
Figure Rest of Middle East and Africa All Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Table Pfizer Inc. All Vaccine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Mitsubishi Tanabe Pharma Corporation All Vaccine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table CSL Ltd. All Vaccine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Emergent BioSolutions Inc. All Vaccine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GlaxoSmithKline plc. All Vaccine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sanofi Pasteur SA All Vaccine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novavax AB All Vaccine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Janssen Pharmaceutical Company All Vaccine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merck & Co. Inc. All Vaccine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Serum Institute of India Ltd. All Vaccine Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global All Vaccine Market Share by Manufacturer
Figure Global All Vaccine Revenue and Market Share by Manufacturer
Table Global All Vaccine Price by Region (2017-2017)
Figure Top 5 All Vaccine Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global All Vaccine Revenue (Millions USD) and Growth Rate (2018-2025)
Table All Vaccine Market Forecast by Regions (2018-2025)
Figure North America All Vaccine Market Forecast (2018-2025)
Figure United States All Vaccine Market Forecast (2018-2025)
Figure Canada All Vaccine Market Forecast (2018-2025)
Figure Mexico All Vaccine Market Forecast (2018-2025)
Figure Europe All Vaccine Market Forecast (2018-2025)
Figure Germany All Vaccine Market Forecast (2018-2025)
Figure France All Vaccine Market Forecast (2018-2025)
Figure UK All Vaccine Market Forecast (2018-2025)
Figure Russia All Vaccine Market Forecast (2018-2025)
Figure Italy All Vaccine Market Forecast (2018-2025)
Figure Rest of Europe All Vaccine Market Forecast (2018-2025)
Figure Asia-Pacific All Vaccine Market Forecast (2018-2025)
Figure China All Vaccine Market Forecast (2018-2025)
Figure Japan All Vaccine Market Forecast (2018-2025)
Figure Korea All Vaccine Market Forecast (2018-2025)
Figure India All Vaccine Market Forecast (2018-2025)
Figure Southeast Asia All Vaccine Market Forecast (2018-2025)
Figure Rest of Asia-Pacific All Vaccine Market Forecast (2018-2025)
Figure South America All Vaccine Market Forecast (2018-2025)
Figure Brazil All Vaccine Market Forecast (2018-2025)
Figure Argentina All Vaccine Market Forecast (2018-2025)
Figure Columbia All Vaccine Market Forecast (2018-2025)
Figure Rest of South America All Vaccine Market Forecast (2018-2025)
Figure Middle East and Africa All Vaccine Market Forecast (2018-2025)
Figure Saudi Arabia All Vaccine Market Forecast (2018-2025)
Figure United Arab Emirates All Vaccine Market Forecast (2018-2025)
Figure Egypt All Vaccine Market Forecast (2018-2025)
Figure Nigeria All Vaccine Market Forecast (2018-2025)
Figure South Africa All Vaccine Market Forecast (2018-2025)
Figure Turkey All Vaccine Market Forecast (2018-2025)
Figure Rest of Middle East and Africa All Vaccine Market Forecast (2018-2025)
Figure Global All Vaccine Forecast by Type (2018-2025)
Figure Global All Vaccine Market Share Forecast by Type (2018-2025)
Figure Global All Vaccine Forecast by Type (2018-2025)
Figure Global All Vaccine Forecast by Valance (2018-2025)
Figure Global All Vaccine Market Share Forecast by Valance (2018-2025)
Figure Global All Vaccine Forecast by Valance (2018-2025)
Figure Global All Vaccine Forecast by Route Of Administration (2018-2025)
Figure Global All Vaccine Market Share Forecast by Route Of Administration (2018-2025)
Figure Global All Vaccine Forecast by Route Of Administration (2018-2025)
Figure Global All Vaccine Forecast by Indication (2018-2025)
Figure Global All Vaccine Market Share Forecast by Indication (2018-2025)
Figure Global All Vaccine Forecast by Indication (2018-2025)
Figure Global All Vaccine Forecast by Distribution Channel (2018-2025)
Figure Global All Vaccine Market Share Forecast by Distribution Channel (2018-2025)
Figure Global All Vaccine Forecast by Distribution Channel (2018-2025)
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|